Antiangiogenic Therapy in Neovascular Age-related Macular Degeneration
- 1 January 2007
- journal article
- review article
- Published by Wolters Kluwer Health in International Ophthalmology Clinics
- Vol. 47 (1) , 117-137
- https://doi.org/10.1097/iio.0b013e31802bd873
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASERetina, 2005
- Ocular neovascularisation and excessive vascular permeabilityExpert Opinion on Biological Therapy, 2004
- Vascular Endothelial Growth Factor: Basic Science and Clinical ProgressEndocrine Reviews, 2004
- Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)Journal of Biological Chemistry, 2001
- Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by HypoxiaJournal of Biological Chemistry, 1995
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGFScience, 1989
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983